TISSUE CONCENTRATION OF NALIDIXIC ACID IN CHRONIC PYELONEPHRITIS.
作者信息
JAMESON R M
出版信息
Br Med J. 1965 Sep 11;2(5462):621-2. doi: 10.1136/bmj.2.5462.621.
Abstract
摘要
相似文献
1
TISSUE CONCENTRATION OF NALIDIXIC ACID IN CHRONIC PYELONEPHRITIS.
Br Med J. 1965 Sep 11;2(5462):621-2. doi: 10.1136/bmj.2.5462.621.
2
CHILD CARE IN GENERAL PRACTICE. URINARY INFECTION.
Br Med J. 1965 Apr 17;1(5441):1043-6.
3
STUDY OF NALIDIXIC ACID.
Invest Urol. 1965 Mar;2:409-16.
4
NEGGRAM (NALIDIXIC ACID) IN THE TREATMENT OF URINARY INFECTIONS.
J Urol. 1964 Nov;92:552-4. doi: 10.1016/S0022-5347(17)64008-4.
5
A CLINICAL TRIAL OF NALIDIXIC ACID (NEGRAM) IN URINARY INFECTIONS.
Br J Clin Pract. 1965 May;19:269-73.
6
A clinical trial of the treatment of gram-negative urinary infections with nalidixic acid.
Br J Urol. 1963 Jun;35:122-4. doi: 10.1111/j.1464-410x.1963.tb02603.x.
7
A CLINICAL TRIAL OF NALIDIXIC ACID: A NEW ANTIBACTERIAL SUBSTANCE.
Med J Aust. 1964 Aug 8;2:225-8. doi: 10.5694/j.1326-5377.1964.tb115677.x.
8
CXCVII. NALIDIXIC ACID.
Practitioner. 1964 May;192:701-6.
9
A clinical trial of nalidixic acid (Negram, WIN. 18,320) in thirty-three patients with urinary infections treated in general practice.
Br J Urol. 1963 Jun;35:125-8. doi: 10.1111/j.1464-410x.1963.tb02604.x.
10
CLINICAL EVALUATION OF NEGGRAM, A NEW ANTIMICROBIAL AGENT: PRELIMINARY REPORT.
Trans Am Assoc Genitourin Surg. 1964;56:135-9.
引用本文的文献
1
Mutators can drive the evolution of multi-resistance to antibiotics.
PLoS Genet. 2023 Jun 13;19(6):e1010791. doi: 10.1371/journal.pgen.1010791. eCollection 2023 Jun.
2
Distribution of gentamicin in body fluids.
Br Med J. 1968 Apr 6;2(5596):22-4. doi: 10.1136/bmj.2.5596.22.
3
Comparative efficacy and safety of nalidixic acid versus trimethoprim/sulfamethoxazole in treatment of acute urinary tract infections in college-age women.
Antimicrob Agents Chemother. 1981 Apr;19(4):598-604. doi: 10.1128/AAC.19.4.598.
4
Effect of renal excretion rate on intrarenal distribution of sulfonamides.
Naunyn Schmiedebergs Arch Pharmakol. 1969;264(4):427-33. doi: 10.1007/BF01002381.
本文引用的文献
1
ABSORPTION, EXCRETION, AND METABOLISM OF A NEW ANTIBACTERIAL AGENT, NALIDIXIC ACID.
Toxicol Appl Pharmacol. 1964 May;6:292-309. doi: 10.1016/0041-008x(64)90070-5.
2
CXCVII. NALIDIXIC ACID.
Practitioner. 1964 May;192:701-6.
3
NALIDIXIC ACID IN URINARY INFECTIONS.
Br Med J. 1963 Nov 23;2(5368):1311-4. doi: 10.1136/bmj.2.5368.1311.
4
NALIDIXIC ACID IN INFECTIONS OF URINARY TRACT. LABORATORY AND CLINICAL INVESTIGATIONS.
Br Med J. 1963 Nov 23;2(5368):1308-10. doi: 10.1136/bmj.2.5368.1308.
5
Pyelonephritis.
J Ark Med Soc. 1962 Nov;59:215-20.
6
A clinical trial of the treatment of gram-negative urinary infections with nalidixic acid.
Br J Urol. 1963 Jun;35:122-4. doi: 10.1111/j.1464-410x.1963.tb02603.x.
Zotero 插件